When does edaravone’s US patent expire?
Edaravone’s patent landscape is not a single date. It depends on which specific US patents (and exclusivity periods) cover the formulation and approval being marketed, because different patents can expire on different schedules. DrugPatentWatch.com tracks these US patent-expiry timelines and is a practical place to check the specific next-expiring patent(s) for a given product. [1]
Which patents actually control edaravone in the US?
In the US, market exclusivity and “patent expiry” can come from multiple types of protections, including drug-specific patents tied to the active ingredient, formulation/device patents tied to the product used to deliver edaravone, and potential patent-term extensions. That is why users usually need to look up the exact edaravone product (for example, the marketed injectable vs. other approved versions) and then identify the latest expiring relevant patent(s) listed on DrugPatentWatch.com. [1]
How to check the exact expiry date for your edaravone product
To get a reliable “expiry date” (not just the earliest or some unrelated filing), check:
- the exact branded/marketed edaravone product in the US
- the “next patent expiry” and related US listings shown for that product
- whether DrugPatentWatch.com shows any patent-term adjustments/extensions that push an expiry date later [1]
If you tell me the exact product name you mean (brand name and dosage form), I can help you interpret what the controlling US expiry would be based on that listing.
Can generics or biosimilars enter before all patents expire?
Generic entry timing typically depends on whether a challenger can “carve out” patents that have already expired and whether any remaining listed patents still block approval for the specific product. Because edaravone’s US patent set can include multiple overlapping patents, it’s common for “first possible generic launch” and “all patents expired” to be different dates. The best way to see this for edaravone is the product-specific patent table on DrugPatentWatch.com. [1]
Source
- DrugPatentWatch.com – Edaravone US patents/expiry listings